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Abstract
Background: Previously, drug-based synchronization procedures were used for characterizing the cell cycle
dependent transcriptional program. However, these synchronization methods result in growth imbalance and
alteration of the cell cycle machinery. DNA content-based fluorescence activated cell sorting (FACS) is able to sort
the different cell cycle phases without perturbing the cell cycle. MiRNAs are key transcriptional regulators of the
cell cycle, however, their expression dynamics during cell cycle has not been explored.
Methods: Following an optimized FACS, a complex initiative of high throughput platforms (microarray, Taqman
Low Density Array, small RNA sequencing) were performed to study gene and miRNA expression profiles of cell
cycle sorted human cells originating from different tissues. Validation of high throughput data was performed
using quantitative real time PCR. Protein expression was detected by Western blot. Complex statistics and
pathway analysis were also applied.
Results: Beyond confirming the previously described cell cycle transcriptional program, cell cycle dependently
expressed genes showed a higher expression independently from the cell cycle phase and a lower amplitude of
dynamic changes in cancer cells as compared to untransformed fibroblasts. Contrary to mRNA changes, miRNA
expression was stable throughout the cell cycle.
Conclusions: Cell cycle sorting is a synchronization-free method for the proper analysis of cell cycle dynamics.
Altered dynamic expression of universal cell cycle genes in cancer cells reflects the transformed cell cycle
machinery. Stable miRNA expression during cell cycle progression may suggest that dynamical miRNA-dependent
regulation may be of less importance in short term regulations during the cell cycle.
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Background
The fine-tuned mechanisms of cell cycle have always
been in the focus of cancer research resulting in a bet-
ter understanding and optimization of the action of
several chemotherapeutic agents [1–3]. Both posttrans-
lational modifications of proteins (e.g. protein-protein
interactions, phosphorylations) and altered transcrip-
tional activity of specific genes contribute to the tightly
controlled regulation of the cell cycle [3]. Analysis of
mRNA transcripts expressed in a cell cycle dependent
manner using high-throughput screening methods have
identified numerous genes used for differentiating ma-
lignant tumors from benign lesions [4–6]. These cor-
relations were presumably due to the possibility that
cell cycle dynamics accelerate in malignant tumors,
resulting in a larger proportion of cells residing in S
and G2 phases [4].
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Former approaches for detecting transcripts expressed in
a cell cycle dependent manner used several synchronization
techniques for arresting the cell cycle at a certain point.
Among others, serum starvation, double thymidine
block, and thymidine-nocodazole block halted the cell
cycle in cultured cells at G0, early S and M phases, re-
spectively [4–6]. After removal of the synchronizing
agent, time-course gene expression data followed by ad-
equate bioinformatics analysis were used for identifying
the cell cycle regulated transcripts [4–6]. However, sev-
eral conflicting arguments have been raised concerning
the usage of these synchronization procedures [7]. Stat-
istical re-examination of a former study [6] surprisingly
revealed that randomization of time-course gene ex-
pression data showed the same strong periodicity in the
expression patterns as those obtained from the original
synchonization experiment. Moreover, synchronization
procedures in general [8], and DNA replication inhibi-
tors such as thymidine in particular, result in the per-
turbance of cell cycle machinery, producing growth
imbalance and unscheduled expression of cyclins [8, 9].
Additionally, cells may lose their synchronization rela-
tively soon after the release from the synchronizing
agent [5, 10] and only a subset of cells reenter the cell
cycle after arrest [5, 11]. Therefore, a set of criteria has
been introduced for the analysis of cell cycle dependent
transcripts [7]. Accordingly, the expression pattern of a
certain gene can be introduced as cell cycle dependent
if (i) no inhibition or starvation method was used for
synchronization, (ii) results are reproducible over sev-
eral experiments (iii) results of additional methods
other than microarrays (e.g. Northern blot, quantitative
real-time polymerase chain reaction – qRT-PCR) sup-
port the findings (iv) expression patterns are confirmed
in non-synchronized experiments (e.g. cells separated
by size or DNA content) and (v) statistically robust ana-
lysis supports the results [7].
The regulation of the cell cycle in general and the cell
cycle dependent transcriptional program in particular is
the consequence of the precise interactions between
cyclin-cyclin dependent kinase complexes and an oscil-
lating network of transcription factors [12, 13]. Add-
itionally, epigenetic mechanisms as microRNA-mediated
regulations contribute to proper cell cycle regulation.
MicroRNAs (miRNAs) are short, ~22 nt long noncoding
RNA molecules regulating gene expression on the post-
transcriptional level targeting the 3’ untranslated regions
of mRNAs [14]. Extensive complementarity results in
mRNA degradation, whereas in the case of short com-
plementarity, transcriptional silencing is achieved by
transcriptional repression [15]. Among other physio-
logical functions, the importance of miRNA-dependent
gene regulation has been confirmed in several key mem-
bers of the cell cycle machinery [16–18], contributing to
miRNA-dependent cell cycle changes [17, 19]. Altered
expression of cell cycle-controlling miRNAs has been re-
ported in neoplasms of various tissues [18, 20, 21]. Add-
itionally, dynamic miRNA expression changes have been
observed during exit from quiescent state due to serum
reintegration into the culture medium of serum starved
cells [22, 23]. In particular, elevated expression of E2F1
and E2F3 in response to mitogenic stimuli have been
shown to enhance the expression of its transcriptional
targets: hsa-let-7 and hsa-miR-16 family members [22].
Moreover, E2F1 has been shown to enhance hsa-miR-15
expression, which inhibits cyclin E, one of the key tran-
scriptional targets of E2F1 [17]. Accordingly, it has been
proposed that such feed-forward loops encompassing
the E2F transcription factors, miRNAs and cyclins con-
tribute to the fine-tuning of cell cycle regulation [17].
However, the potential dynamic miRNA expression
changes between the cell cycle phases of actively cycling
cells without any synchronization or serum shock proce-
dures have not been thoroughly investigated.
Here, for the first time, we show that gene expression
signature obtained from unperturbed cells sorted by
fluorescence activated cell sorting (FACS) based on their
DNA content at different phases of the cell cycle correl-
ate well with former gene expression studies using
synchronization methods. In addition to lower expres-
sion of cell cycle genes in different cell cycle phases, dy-
namic mRNA expression changes were found to be of
greater amplitude in primary, untransformed fibroblasts
as compared to those detected in cancer cell lines,
reflecting the more precise cell cycle regulation in un-
transformed cells with lower proliferation characteristics.
Using numerous high-throughput miRNA-screening
methods, miRNA expression, unlike mRNA expression,
was found to be quite stable throughout the cell cycle
progression in various human cells.
Results
An optimized cell cycle sorting method successfully
differentiates cell cycle phases in various cells
Our optimal cell cycle sorting was able to differentiate
cells residing in various cell cycle phases in all of the
three cell types used (HDFa, NCI-H295R and HeLa
cells) (Fig. 1, panel a-c). The purity of cell cycle sorted
populations varied between cell types and cell cycle
phases (Additional file 1: Table S1), but based on FACS
reanalysis, these sorted cell populations were still more
homogenous than cells obtained after synchronization
procedures [5]. G1 phase was sorted most efficiently in
all cell types with more than 95 % of purity in all cells.
In NCI-H295R and HeLa cells, S phase cells showed
more homogenous population as compared to cells in
G2 phase.
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Optimization of the cell cycle sort was needed for the
sake of achiveving high purity in sorting without dam-
aging or perturbing physiological cell functions. In par-
ticular, the determination of upper limit of sorting time,
the use of a specialized sort medium and the immediate
re-analysis of sorted cells contributed to our results.
Protein expression change confirms the successful sorting
Tyr15 phosphorylation of CDC-2 protein is a tightly
controlled event in cell cycle progression [24], thus the
respective amounts of phospho (Tyr15)-CDC-2 provide
a general hallmark for each phase. Western blot analysis
performed on protein extracts of sorted NCI-H295R and
HeLa cells showed the well known phosphorylation
patterns of CDC-2 (Fig. 1, panel d-e), confirming the
purity of cell cycle sorting on protein level as well.
Gene expression profiling detects cell cycle regulated
transcripts in FACS-sorted cells
The quantity and quality of isolated RNA from sorted
cells were sufficient to perform high throughput gene
expression screening (Additional file 2: Figure S1,
Additional file 1: Table S1). Gene expression profiling,
followed by rigorous statistical analysis detected 55
mRNA transcripts in NCI-H295R cells (Fig. 2, Panel a,
Additional file 1: Table S3, panel B) and 252 mRNA
transcripts in HeLa cells (Fig. 2, Panel b, Additional
file 1: Table S3, panel C) to be expressed in a cell cycle
Fig. 1 Fluorescence activated cell sorting (FACS) analysis of stained cells and validation of cell cycle sorted populations in HDFa, NCI-H295R and
HeLa cells. Panels a-c: FACS analysis shows cell cycle distribution of stained cells before (first image) and after sorting to G1, S and G2 phases
(second, third and fourth images, respectively; Panel a: HDFa, Panel b: NCI-H295R, Panel c: HeLa. Intervals of fluorescence intensity (shown as
vertical bands) were defined to gate G1, S and G2 phases, respectively. Panels d-e: Western blot analysis confirms the high efficacy of cell cycle
sort (Panel d: NCI-H295R, Panel e: HeLa). Density values of phospho(Tyr15)-CDC-2 were first normalized to β-actin loading control and were
further normalized to G1 phase (displayed above each band)
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dependent manner. Note that the majority of detected
gene expression changes share a common manner: ex-
pression rises as cell cycle proceeds. Additionally,
clustering showed that S and G2 phases’ expressional
patterns are closer to each other than to G1 phase.
Statistical analysis of HDFa microarray data failed to
detect genes with significantly altered expression,
however, the functional bioinformatics analysis of the
gene expression changes of greater than a twofold
change (FC > 2, Fig. 2, Panel f, Additional file 1: Table
S3, panel A) supports the concept that these changes
strongly influence cell cycle progression. Moreover,
the successful qRT-PCR validation of the chosen FC >
2 genes (Fig. 2, Panel c) and the significant correlation
of gene expression changes of cell cycle sorted with
former synchronization-based experiments in primary
fibroblasts (Fig. 3, Panel b) further confirm the rele-
vance of our approach.
Gene expression changes observed by qRT-PCR experi-
ments of six genes chosen upon microarray analysis con-
firmed the microarray results in all of the three cells
(Fig. 2, Panel c-e). Specifically, all the six genes chosen for
the qPCR validation were present in the significant (NCI-
H295R, HeLa) or FC > 2 (HDFa) lists. Moreover, ARH-
GAP11A, KIF14 and GTSE1 were previously found to be
expressed in a cell cycle dependent fashion in primary
Fig. 2 High throughput gene expression profiling, qRT-PCR validation and functional bioinformatics analysis of cell cycle dependent transcription
in HDFa, NCI-H295R and HeLa cells. Panels a-b: Heat map of mRNA transcripts with significantly different expression between cell cycle phases
(Panel a: NCI-H295R, Panel b: HeLa). Above the heat maps, hierarchical clustering upon differently expressed genes are also shown (additional
information, including the list of gene symbols and descriptions can be found in Additional file 1: Table S3, panels B and C). Panels c-e: qRT-PCR
validation of six genes chosen upon microarray analysis (Panel c: HDFa, Panel d: NCI-H295R, Panel e: HeLa). In each case ΔCt value was normalized to
G1 phase (ΔΔCt) and was subjected to FC = 2-ΔΔCt transformation. Error bars show standard deviation. Asterisks mark statistical significance (p < 0.05).
Panels f-h: Molecular and cellular functions concerned by gene expression alterations in cell cycle phases. Δ(G2-G1) gene expression changes
of significantly differently expressed genes (Panel g: NCI-H295R, Panel h: HeLa) or genes with fold change > 2 expression (Panel f: HDFa) were
subjected to IPA core analysis. In each cell, the five most significantly concerned networks are shown. Significance threshold (p = 0.05) corresponds to
–log(p-value) = 1.301. For additional molecular and cellular functions see Additional file 2: Figure S2
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fibroblasts [5] and HeLa cells [4], while ASPM and SKA1
genes were found to be cell cycle regulated in primary
fibroblasts [5]. The successful validation of these well-
known cell cycle genes in all three cell types analyzed here
further confirms our cell cycle sorting method.
Functional bioinformatics analysis was used to detect
altered pathways based on our microarray results. As a
further confirmation of our method, ”Cell cycle” ”Cellular
assembly and organization” and ”DNA replication, re-
combination and repair” were the molecular and cellular
functions most concerned by gene expression changes in
all three cells (Fig. 2, Panel f-h).
Comparison of cell cycle dependent expression between
cell cycle sort and former synchronization based data
Several conflicting arguments arose on the applicability
of synchronization procedures to define transcripts
with cycling expression in unperturbed cells [7]. There-
fore we aimed to compare expression changes between
cell cycle phases detected by gene expression profiling
Fig. 3 Comparison of cell cycle dependent gene expression observed by cell cycle sort and synchronization experiments and analysis of gene
expression dynamics during the cell cycle in various cell types. Panel a: Venn diagram of cell cycle dependent genes detected in cell cycle
sorted primary fibroblasts (HDFa SORT), in synchronized primary fibroblasts (PF synchr – data from [5]), in cell cycle sorted HeLa cells (HeLa
SORT) and in synchronized HeLa cells (HeLa synchr – data from [4]). Intersections present the number of commonly found genes. For gene
lists see Additional 1: Table S4. Panels b-c: Correlation analysis of gene expression differences using normalized expression values obtained
from microarray experiments. Pearson’s correlation coefficient was calculated from Δ(G2-G1) expression changes detected by cell cycle sort
and former synchronization experiments in primary fibroblasts (synchronization method: serum starvation – SS, Panel b) and HeLa (synchronization
method: double thymidine block – DT, Panel c) cells. Correlation coefficients are displayed. Asterisks mark statistical significance (p < 0.05).
For additional correlation calculations see Additional 2: Figures S3 and S4. Panels d-e: Analysis of normalized gene expression values of
different cell types. Normalized gene expression of 127 cycling genes exported from microarray data (Panel d) and 10 cycling genes
exported from qRT-PCR data (Panel e) were analyzed. Note the lower ΔCt(ACTB) values mean higher expression values. Error bars show
standard deviation. Asterisks mark statistical significance (p < 0.05). Panels f-g: Analysis of mean gene expression fold change between cell
cycle phases of different cell types. Absolute values of fold change of 127 cycling genes exported from microarray data (Panel f) and 10
cycling genes exported from qRT-PCR data (Panel g) of cell cycle sort experiments were analyzed. Error bars show standard deviation.
Asterisks mark statistical significance (p < 0.05)
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in synchronization and cell cycle sort based experi-
ments. Because synchronization based time course gene
expression data in adrenocortical cell line have not
been previously published, comparisons were made
with primary fibroblasts and HeLa cells. Pearson’s
method showed significant correlation between gene
expression changes observed in synchronization based
and cell cycle sort based experiments, confirming previ-
ous synchronization experiments by a synchronization-
free method in unperturbed cells (Fig. 3, Panel a-c,
Additional file 2: Figures S3 and S4, Additional file 1:
Table S4).
Additionally, Gene Ontology (GO) Term analysis
was performed on the HeLa cell cycle dependent tran-
scriptional program to analyze the possible difference
in biological processes affected by cell cycle sort and
synchronization procedures. As both of cell cycle sort-
based and synchronization-based results are only ap-
plicable in HeLa cells, we performed the analysis on
three gene lists: genes unique to the HeLa cell cycle
sort experiment (unique HeLa SORT), genes unique to
the HeLa synchronization experiment (unique HeLa
synchr) and the overlap between these two lists. All
three lists were enriched with cell cycle-related processes;
however, the overlap between the two experiments pre-
sented the most significant enrichment of cell cycle-
associated biological processes, cross-validating important
cell cycle genes detected by both the synchronization-
based and cell cycle sort-based procedures. All the GO
terms detected in the unique HeLa SORT list were de-
tected in the overlap list, however, interestingly, five
out of eight GO terms detected in the unique HeLa
synchr list were unique to this list of genes, not being
present in the analysis of the unique HeLa SORT or
overlap gene lists (Table 1 and Additional file 1: Table S5).
Magnitude of gene expression alterations during cell
cycle progression in untransformed and cancer cells
QRT-PCR validation of microarray experiments (Fig. 2,
Panel c-e) indicated that gene expression changes might
be characterized by different amplitudes in primary vs.
cancer cells. Therefore, we analyzed the expression pro-
files and cell cycle dynamics of genes displaying altered
expression between cell cycle phases in both primary un-
transformed (HDFa) and transformed cancer (HeLa)
cells (127 genes present in both HDFa SORT and HeLa
SORT gene lists, Fig. 3, Panel a). Significantly lower ex-
pression values were found in primary untransformed
compared to cancer cells in G1, S and G2 phases as well
(Fig. 3, Panel d-e). For the analysis of mRNA dynamics
during cell cycle in untransformed and cancer cells, dif-
ferences in mean fold changes of expression of genes
commonly altered in HDFa and HeLa cell cycle sort ex-
periments were calculated and evaluated (Fig. 3, Panel
f-g). Among several significant alterations, a robust dif-
ference in mean fold change of gene expression was ob-
served in G1/S transition between primary fibroblasts
and cancer (NCI-H295R and HeLa) cells based on both
microarray and qRT-PCR results. During the cell cycle,
cycling genes had lower basal expression, but they demon-
strated expression changes of significantly greater ampli-
tude in primary non-transformed fibroblasts, than in
transformed cancer (NCI-H295R and HeLa) cells.
High-throughput screening of miRNAs differently
expressed during the human cell cycle
Three high-throughput platforms (microarray, TaqMan
Low Density Array and Illumina small RNA Sequen-
cing) of miRNA expression were used to detect cell
cycle dependent miRNA expression (Fig. 4, Panel a-d,
Additional file 2: Figure S5). Among them, microarray
(Fig. 4, Panel a and c) displayed the lowest dynamic
range and was unable to detect miRNAs of altered
expression between cell cycle phases in HDFa and NCI-
H295R cells. TaqMan Low Density array (Fig. 4, Panel
b) performed on RNA isolated from sorted NCI-H295R
cells detected 8 miRNAs of altered expression between
cell cycle phases (among which only hsa-miR-10b, hsa-
miR-128a and hsa-miR-890 had fold change values ex-
ceeding 2), however qRT-PCR validation of selected
miRNAs failed to confirm the results (Additional file 2:
Figure S6). Among the three platforms used in our
study, small RNA sequencing was found to have the
largest dynamic range in detection of miRNA expres-
sion alterations (Fig. 4, Panel d and Additional file 2:
Figure S5). Still, statistical analysis detected only 11
miRNAs with altered expression in HeLa cells, of which
only four miRNAs (hsa-miR-146b, hsa-miR-577, hsa-
miR-877 and hsa-miR-193b*) had FC > 2 expression
change between cell cycle phases. QRT-PCR measure-
ments, similar to that of TLDA validation attempt,
failed to validate differential expression in NCI-H295R
and HeLa cells (Additional file 2: Figures S5 and S6).
For further validation four other miRNAs showing stable
expression in different cell types and cell cycle phases
based on the high-throughput data were selected for qRT-
PCR control analysis, which confirmed the stable expres-
sion pattern (Additional file 2: Figure S6).
Among several cell cycle regulator miRNAs, members
of the hsa-miR-16 family were found to display dy-
namic changes in expression between serum-starved
G0 and actively proliferating state [23]. Therefore, we
analyzed expression changes of the hsa-miR-16 family
members: hsa-miR-16, hsa-miR-15a and hsa-miR-503 in
our high-throughput data (Fig. 4, Panel a-d and Additional
file 2: Figure S5, Panel a) and performed qRT-PCR analysis
as well (Fig. 4, Panel e-g). In the case of hsa-miR-15a,
small RNA sequencing detected two-fold alteration in
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Table 1 GO term analysis of the cell cycle dependent transcriptional program of HeLa cells
GO Term Gene count p-value Bonferroni-corrected p-value
Panel A – genes unique to HeLa SORT experiment
GO:0007049 cell cycle 19 4.62 × 10−6 3.32 × 10−3
GO:0000280 nuclear division 10 1.99 × 10−5 1.42 × 10−2
GO:0007067 mitosis 10 1.99 × 10−5 1.42 × 10−2
GO:0000087 M phase of mitotic cell cycle 10 2.29 × 10−5 1.64 × 10−2
GO:0048285 organelle fission 10 2.73 × 10−5 1.95 × 10−2
GO:0051301 cell division 11 3.41 × 10−5 2.43 × 10−2
GO:0007017 microtubule-based process 10 5.94 × 10−5 4.19 × 10−2
Panel B – genes unique to HeLa synchronization experiment
GO:0006259 DNA metabolic process 15 1.20 × 10−8 7.35 × 10−6
GO:0007049 cell cycle 17 5.65 × 10−8 3.45 × 10−5
GO:0006281 DNA repair 10 2.23 × 10−6 1.36 × 10−3
GO:0006974 response to DNA damage stimulus 11 2.59 × 10−6 1.58 × 10−3
GO:0022403 cell cycle phase 11 6.53 × 10−6 3.99 × 10−3
GO:0006260 DNA replication 8 1.25 × 10−5 7.63 × 10−3
GO:0033554 cellular response to stress 12 1.67 × 10−5 1.02 × 10−2
GO:0000278 mitotic cell cycle 10 1.89 × 10−5 1.15 × 10−2
Panel C – overlap of genes of HeLa SORT and synchronization experiments
GO:0022403 cell cycle phase 46 2.21 × 10−49 1.40 × 10−46
GO:0000279 M phase 43 1.12 × 10−48 7.09 × 10−46
GO:0000278 mitotic cell cycle 44 3.69 × 10−48 2.33 × 10−45
GO:0022402 cell cycle process 48 2.39 × 10−46 1.51 × 10−43
GO:0007049 cell cycle 52 6.85 × 10−46 4.33 × 10−43
GO:0007067 mitosis 37 3.87 × 10−45 2.45 × 10−42
GO:0000280 nuclear division 37 3.87 × 10−45 2.45 × 10−42
GO:0000087 M phase of mitotic cell cycle 37 7.76 × 10−45 4.90 × 10−42
GO:0048285 organelle fission 37 1.81 × 10−44 1.15 × 10−41
GO:0051301 cell division 32 3.01 × 10−32 1.90 × 10−29
GO:0007017 microtubule-based process 23 7.87 × 10−21 4.97 × 10−18
GO:0000226 microtubule cytoskeleton organization 17 7.86 × 10−17 7.02 × 10−14
GO:0007346 regulation of mitotic cell cycle 15 8.68 × 10−14 5.48 × 10−11
GO:0051726 regulation of cell cycle 19 1.68 × 10−13 1.06 × 10−10
GO:0007051 spindle organization 10 2.28 × 10−12 1.44 × 10-.9
GO:0007059 chromosome segregation 11 2.02 × 10−11 1.28 × 10-.8
GO:0010564 regulation of cell cycle process 12 2.90 × 10−11 1.84 × 10-.8
GO:0007010 cytoskeleton organization 18 1.70 × 10−10 1.08 × 10-.7
GO:0051783 regulation of nuclear division 9 6.98 × 10−10 4.41 × 10-.7
GO:0007088 regulation of mitosis 9 6.98 × 10−10 4.41 × 10-.7
GO:0000070 mitotic sister chromatid segregation 8 8.88 × 10−10 5.61 × 10-.7
GO:0000819 sister chromatid segregation 8 1.09 × 10-.9 6.89 × 10-.7
GO:0051276 chromosome organization 17 7.07 × 10-.9 4.47 × 10-.6
GO:0000075 cell cycle checkpoint 9 3.58 × 10-.8 2.26 × 10-.5
GO:0040001 establishment of mitotic spindle localization 5 6.00 × 10-.8 3.79 × 10-.5
GO:0051656 establishment of organelle localization 8 9.92 × 10-.8 6.27 × 10-.5
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expression in NCI-H295R and HeLa cells as well and
qRT-PCR analysis further confirmed some small, but sig-
nificant expression changes in all three cell types.
Discussion
With the advent of high-throughput transcriptional
profiling, the precise analysis of the cell cycle transcrip-
tion program became possible. Time course gene ex-
pression data after various synchronization procedures
were used for gene expression profiling on microarray
platforms [4–6] which demonstrated the cell cycle tran-
scription program in various cell types including un-
transformed primary [5, 6] and transformed cancer
cells [4].
However, questions were raised on the applicability of
synchronization procedures in the analysis of cell cycle
dependent transcriptional profiling [7]. In fact, growth
imbalance and unscheduled expression of key cell cycle
factor cyclins were demonstrated due to synchronization
procedures [8, 9]. Additionally, cells failed to retain their
synchronization relatively soon after depriving the
synchronization agent from growth medium [5, 10]. A
rigorous set of criteria was introduced by Shedden and
Cooper concerning the analysis of cell cycle dependent
gene expression [7] and, therefore, novel methods satis-
fying these criteria were needed. Centrifugal elutriation
[25] and cell cycle sort [26–28] are two synchronization-
free methods satisfying the Shedden and Cooper criteria
without perturbing the cell cycle machinery. However, to
our knowledge no detailed study using these methods
to determine cell cycle dependent gene expression in
human cells has been published to date. Upon centrifu-
gal elutriation, cells are differentiated upon the size of
each cell [25], while during cell cycle sorting by FACS
the amount of DNA in each cell is used for separation
[27, 28]. Both methods achieved efficient separation of
cell cycle phases [12, 13, 27–29]. Although proper seg-
regation of cell cycle phases by cell cycle sort may be
optimal in cells lacking aneuploidy, cells presenting an-
euploidy may as well be introduced to cell cycle sort
Table 1 GO term analysis of the cell cycle dependent transcriptional program of HeLa cells (Continued)
GO:0030071 regulation of mitotic metaphase/anaphase transition 6 1.12 × 10-.7 7.07 × 10-.5
GO:0007093 mitotic cell cycle checkpoint 7 1.23 × 10-.7 7.76 × 10-.5
GO:0051653 spindle localization 5 1.78 × 10-.7 1.13 × 10-.4
GO:0051293 establishment of spindle localization 5 1.78 × 10-.7 1.13 × 10-.4
GO:0048015 phosphoinositide-mediated signaling 8 5.37 × 10-.7 3.39 × 10-.4
GO:0008283 cell proliferation 14 6.95 × 10-.7 4.39 × 10-.4
GO:0051640 organelle localization 8 7.28 × 10-.7 4.60 × 10-.4
GO:0007052 mitotic spindle organization 5 1.14 × 10-.6 7.17 × 10-.4
GO:0051329 interphase of mitotic cell cycle 8 1.57 × 10-.6 9.90 × 10-.4
GO:0051325 interphase 8 1.90 × 10-.6 1.20 × 10-.3
GO:0007018 microtubule-based movement 8 2.92 × 10-.6 1.85 × 10-.3
GO:0000910 cytokinesis 6 2.93 × 10-.6 1.85 × 10-.3
GO:0033043 regulation of organelle organization 10 2.99 × 10-.6 1.89 × 10-.3
GO:0010948 negative regulation of cell cycle process 5 1.01 × 10-.5 6.36 × 10-.3
GO:0007094 mitotic cell cycle spindle assembly checkpoint 4 2.62 × 10-.5 1.64 × 10-.2
GO:0045841 negative regulation of mitotic metaphase/anaphase transition 4 2.62 × 10-.5 1.64 × 10-.2
GO:0031577 spindle checkpoint 4 3.47 × 10-.5 2.17 × 10-.2
GO:0045839 negative regulation of mitosis 4 3.47 × 10-.5 2.17 × 10-.2
GO:0051784 negative regulation of nuclear division 4 3.47 × 10-.5 2.17 × 10-.2
GO:0051439 regulation of ubiquitin-protein ligase activity during mitotic cell cycle 6 4.48 × 10-.5 2.79 × 10-.2
GO:0051438 regulation of ubiquitin-protein ligase activity 6 7.05 × 10-.5 4.36 × 10-.2
GO:0051303 establishment of chromosome localization 4 7.10 × 10-.5 4.39 × 10-.2
GO:0050000 chromosome localization 4 7.10 × 10-.5 4.39 × 10-.2
Gene lists from the Venn diagram (Fig. 3, Panel a) and Additional file 1: Table S4 were subjected to Gene Ontology term analysis. Genes unique to HeLa SORT
experiment (HeLa SORT \ HeLa synchr - Panel A), unique to HeLa synchr experiment (HeLa synchr \ HeLa SORT – Panel B) and the overlap between these two lists
(HeLa SORT ∩ HeLa synchr – Panel C) were the input gene lists, respectively
Gene count represents the number of genes from the input list being present in the corresponding GO term. Gene symbols are shown in Additional file 1: Table
S5. Only statistical significant (Bonferroni-corrected p-value < 0.05) GO terms are presented. Bold lettered GO terms correspond to unique GO terms found only
upon the analysis of either unique HeLa SORT or unique HeLa synchr gene lists
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until proper further confirmation of cell cycle sort (de-
tection of the different expression of key cell cycle reg-
ulators e.g. Tyr-15 phosphorylation of CDC-2 [24])
supports the results. In our results, dynamic changes of
Tyr-15 phosphorylation of CDC-2 in HeLa show as
great variability as in NCI-H295R cells, confirming suc-
cessful segregation of cell cycle phases in HeLa cells as
well.
Here, using the cell cycle sort method, we report a
comparative analysis of the cell cycle dependent gene
transcriptional profile of human untransformed pri-
mary (fibroblasts) and cancer (adrenocortical and cer-
vical) cells. Functional bioinformatics analysis revealed
cell cycle related molecular and cellular functions to be
mostly concerned with these transcriptional alterations.
As time-course gene expression data from previous
synchronization-based studies regarding primary hu-
man fibroblasts [5] and HeLa cells [4] were available,
we performed a re-analysis of these data to compare
synchronization-based and cell cycle sorting-based re-
sults. Upon the significant correlation between our data
and these earlier results, we conclude that data ob-
tained from cell cycle sort experiments confirm earlier
results demonstrating cell cycle dependent gene expres-
sion in human cells, as well as it satisfies the rigorous
criteria described above [7].
Moreover, GO term analysis was performed to assess
biological processes related to the HeLa cell cycle
dependent transcriptional program. The overlap be-
tween HeLa cell cycle sort and HeLa synchronization
Fig. 4 Analysis of cell cycle dependent miRNA expression by high-throughput screenings methods and individual qRT-PCR in HDFa, NCI-H295R
and HeLa cells. Panels a-d: Fold change (log2) of miRNA expression in S/G1, G2/S and G2/G1 phases observed by microarray (Panel a: NCI-H295R
cells, Panel c: HDFa cells), TaqMan Low Density Array (Panel b: NCI-H295R cells) and Illumina Small RNA Sequencing (Panel d: HeLa cells). Grey
background corresponds to fold change≤ 2 between cell cycle phases. Colored squares represent miRNAs with significantly different expression
in cell cycle phases obtained by statistical analysis of high-throughput data. Colored circles represent some members of the hsa-miR-16 family, if
available. For further high-throughput data of NCI-H295R cells (Illumina Small RNA Sequencing) see Additional 2: Figure S5. For qRT-PCR
measurement data see Additional 2: Figure S6. Panels e-g: QRT-PCR measurements of hsa-miR-16 family members hsa-miR-16, hsa-miR-15a
and hsa-miR-503 in HDFa (Panel e), NCI-H295R (Panel f) and HeLa (Panel g) cells. In each case ΔCt values were normalized to G1 phase
(ΔΔCt) and were subjected to FC = 2-ΔΔCt transformation. Error bars show standard deviation. Asterisks mark statistical significance (p < 0.05)
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experiments showed a robust enrichment of cell cycle-
related GO terms, cross-validating the key players of
the cell cycle dependent transcriptional program. Add-
itionally, cell cycle-related biological processes were
enriched in both the unique to HeLa cell cycle SORT
and the unique to HeLa synchonization gene lists.
However, interestingly, the majority of GO terms de-
tected in the unique HeLa synchronization gene list
were absent from the overlap gene list, indicating some
specific mechanisms related to synchronization proce-
dures. The specific presence of ”response to DNA
damage stimulus” and ”cellular response to stress” and
the induction of ”DNA repair” GO terms confirms the
replication stress as a consequence of synchronization
procedures [8, 9, 30]. These analyses further confirm
that our synhronization-free method of cell cycle sort
charactherises more specifically the cell cycle of unper-
turbed cells than the synchronization-based methods.
We also investigated the eventual difference of cell
cycle regulated transcriptional program in human un-
transformed and cancer cells. Whitfield et al. demon-
strated that genes exhibiting cell cycle regulated
expression were overexpressed in malignant tumors
reflecting the malignancy signature of neoplasms [4].
This was explained by the fact that tumors contain
more cycling cells [4]. Cell cycle dynamics alter dis-
proportionally during malignant transformation [31]:
activation of oncogenes HRAS, SRC, MYC, CCND1,
CCNE [32–34], and loss of tumor suppressor genes as
PTEN [35] shortens G1 phase [31], while loss of key
M phase regulators LZTS1 and LATS2 results in M
phase shortening [31, 36, 37]. These alterations lead to a
relatively larger portion of cells residing in S and G2
phases. Additionally, certain gene clusters were confirmed
to exhibit cell cycle dependent expression in either pri-
mary untransformed or transformed cancer cells [5], dif-
ferentiating cells upon malignant transformation.
Our results contribute to the notion of different tran-
scriptional regulation in untransformed and cancer cells.
Since we have analyzed only three human cell types of
different tissue origin, we can not draw a definitive con-
clusion universal to the cell cycle effects of malignant
transformation. However, based on our analysis we may
hypothesize that genes displaying universal cell cycle
dependent expression in untransformed and cancer cells
display altered expression in each phase and dynamic
changes of different amplitude (Fig. 5). MRNA expres-
sion was found to be higher in G1, S and G2 phases as
well, therefore, in addition to altered cell cycle distribu-
tion, basal, phase-independent up-regulation of these
cell cycle genes may as well constitute to the well ob-
served higher expression in malignant cancers. Dynamic
mRNA expression differences between G1 and S phases
were of greater amplitude in untransformed primary
cells than in cells undergoing malignant transformation.
This may be explained by the longer and more tightly
controlled G1 phase and G1/S transition observed in un-
transformed, primary cells [31], as it reflects the more
precisely regulated cell cycle machinery in untrans-
formed cells. Moreover, MYC amplification stimulates
E2F expression in cancer cells, facilitating the commit-
ment to cell division [38, 39]. This facilitated regulation
of the G1/S transition may as well contribute to smaller
expression changes of the cell cycle dependent transcrip-
tional program.
MiRNAs have a well established role in the regulation
of the cell cycle [19]. Oncogenic (onco-miRs) and
tumor-suppressor (TS-miRs) miRNAs were confirmed
Fig. 5 Schematic presentation of the hypothesis concerning expression dynamics of mRNAs and miRNAs during the cell cycle phases in primary
untransformed and cancer cells. Relative expression changes in G1, S and G2 phases of a representative cell cycle gene and miRNA in untransformed
primary (Panel a) and transformed cancer (Panel b) cells. Relative expression changes of mRNAs exhibiting cell cycle dependent expression (dark blue)
and cell cycle associated miRNAs (green) are shown. Blue double arrows mark the amplitude of dynamic expression range in cell cycle
phases. Note the different phase-specific expression values and the different dynamic expression range in the two cell types. Upon our
results, genes exhibiting cell cycle dependent expression profile in untransformed cells are characterized with lower expression levels
throughout the cell cycle, however they possess greater variance in expression levels than in transformed, cancer cells. MiRNAs, however,
do not display cell cycle dependent expression
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as modifiers of key cell cycle agents, accelerating or de-
celerating cell cycle progression [40, 41]. Long-term
miRNA-mediated cell cycle changes contribute to ma-
lignant transformation in a variety of neoplasms [19,
42–46]. Additionally, the role of miRNA-mediated
regulation has been confirmed in the transition from
quiescent state to actively proliferating state [19, 23]. In
particular, mitogenic stimuli enhances cell cycle pro-
gression by stimulating key transcriptional factors of
the E2F family, which in turn enhances members of the
hsa-let-7 and hsa-miR-16 families [17, 22, 23]. These
well-known TS-miRs target key cell cycle cyclins as
cyclin E, fine-tuning the proper cell cycle progression
[17]. However, the proposed cell cycle dependent
miRNA expression pattern [19] has not been thor-
oughly investigated, as according to our knowledge only
one synchronization study identifying some cell cycle
regulated miRNAs has been published to date [47].
Our study aiming to detect miRNA expression changes
between cell cycle phases included the application of
miRNA microarray, qPCR-based TLDA and Illumina
small RNA sequencing. Microarrays are widely used for
high throughput miRNA profiling and produce results
which can be validated in high percentage by qPCR
[48]. However, obtaining negative results prompted us
for further analysis using qPCR-based TLDA and Illu-
mina small RNA sequencing. The latter approach has
larger dynamic range of detection allowing us to success-
fully detect smaller, but significant alterations [49, 50].
QPCR-based TLDA results however can be most success-
fully validated by single tube individual miRNA-specific
qPCR as primer sequences used in TLDA does not differ.
Analysis of the three human cells (two cancer cell lines
and one primary cell) on three high-throughput miRNA
expression platform in our study revealed that miRNA
expression profile throughout the cell cycle phases was
quite stable (Fig. 5). Surprisingly, our systematic study
using multiple high-throughput platforms indicated the
lack of validable cell cycle dependent miRNA expression,
and also showed that fold change differences are of small
amplitude, especially in the light of the robust and expli-
cit changes observed in mRNA expressions of the very
same cell stage samples. More than 50 % of miRNA
genes are located in cancer-associated genomic regions
or in fragile sites, being continuously downregulated or
deleted in cancers [40, 51]. Therefore, the loss of TS-
miRs and the activation of onco-miRs are specifically
involved in the long-term malignant transformation.
Moreover, with the loss of genetic regions containing
miRNA genes, the possibility of their dynamic regula-
tory functions throughout the cell cycle is lost as well
[40, 51]. Additionally, miRNA-dependent gene regula-
tion was found to be a much slower process than previ-
ously thought, due to certain bottlenecks related to the
complex biogenesis and maturation processes or delays
of miRNAs loading into Argonaute proteins [52]. Ac-
celerated turnover was proposed to be necessary for
certain miRNAs to be possibly involved in dynamic cell
cycle regulation [52]. Such accelerated turnover has
been confirmed in the case of the hsa-miR-16 family
[23]. This family has been identified as a cluster of TS-
miRs [19], downregulated in various types of cancers
[19, 42–44] and associated with quiescent state [23].
Our results indicated some minor miRNA expression
changes, especially in the case of hsa-miR-15a, however,
expression changes were not fully congruent in the
three cell types studied, suggesting that the well known,
cell type specific expression of miRNAs may contribute
to this phenomenon.
Finally, it is of utmost importance to address the limi-
tations of our study. Firstly, upon the analysis of three
human cell types of different tissue origin we can not
draw a general conclusion concerning the difference of
the expression dynamics of the universal cell cycle genes.
Secondly, although different culture conditions may have
some effect on the observed cell cycle differences, our
method has much less effects on cell cycle alterations
compared to previous serum shock-based or inhibitive
synchronization-based processes.
Conclusions
In conclusion, successful utilization of cell cycle sort as a
novel method for the analysis of cell cycle transcriptional
program in our study confirmed the previously identified
cell cycle transcriptional regulation. Different phase-
dependent and phase-independent mRNA expression
dynamics of cell cycle genes in human untransformed
and cancer cells were revealed, reflecting the altered cell
cycle machinery in cancer cells at the transcriptional
level. Perhaps more interestingly, the application of vari-
ous high-throughput platforms (microarray, TLDA,
Small RNA Sequencing) for miRNA profiling showed
that miRNA expression dynamics are unaltered during
the active cell cycle at the G1/S and S/G2 transitions.
Methods
Cell culture
Human adrenocortical cancer cell line NCI-H295R and
human cervical cancer cell line HeLa were obtained
from the American Type Culture Collection (ATCC),
while human dermal fibroblast (HDFa) cells were ob-
tained from Gibco (Life Technologies). NCI-H295R cells
were cultured in Dulbecco’s modified Eagle’s medium/
Nutrient Mixture F-12 Ham (DMEM: F12) supple-
mented with 6.25 ng/ml insulin, 6.25 ng/ml transferrin,
6.25 ng/ml sodium selenite, 1.25 mg/ml bovine serum
albumine, 5.35 ng/ml linoleic acid, 1 % HEPES, 1 %
Penicillin-Streptomycin, 2.5 % L-glutamine (Sigma-
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Aldrich Chemical Co.) and 2.5 % Nu-Serum (BD Biosci-
ences). HeLa cells were cultured in Dulbecco’s modified
Eagle’s medium/Nutrient Mixture F-12 Ham (DMEM:
F12, Sigma-Aldrich Chemical Co.) supplemented with
10 % fetal bovine serum (Gibco by Life Technologies)
and 1 % antibiotic-antimycotic solution (Sigma-Aldrich
Chemical Co.). HDFa cells were cultured in Medium
106 supplemented with low serum growth supplement
(LSGS, Gibco by Life Technologies). All cells were cul-
tured at 37 °C in a humidified 5 % CO2 atmosphere.
DNA content based fluorescence activated cell
sorting (FACS)
HDFa, NCI-H295R and HeLa cells were cultured in
150 cm2 cell culture flasks until 90 % confluency. Cells
were trypsinized, washed, resuspended in complete
medium and counted. Vybrant DyeCycle Orange (Mo-
lecular Probes by Life Technologies) was used to stain
genomic DNA stoichiometrically in living cells (approxi-
mate fluorescence excitation and emission maxima were
519 nm and 563 nm, respectively), and was added in
1:500 dilution to 1 × 106 cells/ml cell suspension. After
incubation at 37 °C for 30 min, protected from light,
cells were centrifuged at 1000 rpm for 10 min and were
resuspended in the sort medium (Hank’s Balanced Salt
Solution without Ca2+ and Mg2+, containing 2 % fetal
calf serum). FACSAria III cell sorter (Becton-Dickinson,
Franklin Lakes, NJ, USA) was used for cell cycle analysis
and sorting using 488 nm Argon laser. The fluorescence
emission of Vybrant DyeCycle Orange was separated by
a 556 longpass filter and detected through a 585/42
bandpass filter. At least 100,000 events were collected
for analysis. Upon cell cycle analysis, cell populations re-
sembling G1, S and G2 phases were gated according to
cellular DNA quantity. Sorting did not exceed 30 min
and all sorted populations were validated by flow cytom-
etry analysis. Data were analyzed by BD FACSDiva
v6.1.3 software (BD Biosciences, San Jose, CA, USA).
Thereafter, cells were centrifuged, washed with ice-cold
PBS and resuspended in QIAzol lysis reagent (Qiagen)
or Western blot lysis buffer for subsequent RNA or pro-
tein isolation, respectively. Until RNA isolation or West-
ern blot, samples were stored at −80 °C. Optimization
from the protocol supplied by the manufacturer included
the use of sort medium, concentration of the cell suspen-
sion before FACS analysis, respecting an upper time limit
for sorting and immediate FACS reanalysis upon every cell
cycle-sorted population.
Protein isolation and Western blot
Samples were thawed on ice, sonicated with ultrasound
and incubated on ice for 30 min. Thereafter, samples were
centrifuged at 13000 rpm and 2 °C for 15 min. Protein
concentration was determined according by Bradford
method using Varioskan Flash spectral scanning reader
(Thermo Scientific) [53]. Optical density was determined
at 595 nm. Samples were mixed with β-mercaptoethanol
containing Laemli buffer and were incubated at 99 °C for
5 min. Thereafter, equal amount of samples were loaded
on a 10 % polyacrylamide gel and electrophoresis was con-
ducted on a Mini Protean electrophoresis equipment
(Bio-Rad). Overnight blotting at 4 °C was performed to
transfer proteins to a PVDF membrane (Millipore, Biller-
ica, MA). Blotting efficiency was determined by Ponceau
staining. Membranes were blocked with 5 % non-fat dry
milk in TBS for 60 min at room temperature, and were in-
cubated with primary phospho-CDC-2 (Tyr15) antibody
(Cell Signaling Technology, cat. No.: 9111, dilution: 1:500)
at 4 °C for 16 h. Thereafter, membranes were washed 5
times with 0.05 % Tween-20 containing TBS, and were
incubated with secondary antibody (Cell Signaling Tech-
nology, cat. No.: 7074, dilution: 1:2000). All antibodies
were diluted in 1 % non-fat dry milk containing TBS. After
exposure to SuperSignal West Pico Chemiluminescent
Substrate (Thermo Scientific), signals were visualized by
Kodak Image Station 4000MM Digital Imaging System.
Thereafter membranes were stripped with mild stripping
buffer (0.2 M glycine, 0.1 % sodium dodecyl sulfate,
0.1 % Tween-20, pH = 2.2) by gentle agitation for
45 min at room temperature, and were blocked again
for subsequent detection of loading control β-actin
(Cell Signaling Technology, cat. No.: 4967, dilution:
1:2000). Membrane blocking, antibody incubations and
signal detection were carried out exactly as in the case
of phospho-CDC-2 detection. Densitometry of the de-
tected bands was performed by Kodak Image Station.
β-actin was used as loading control.
RNA isolation, messenger RNA profiling and validation
by qRT-PCR
Total RNA was isolated using miRNeasy Mini Kit (Qia-
gen), according to the manufacturer’s instructions and
was eluted in 50 uL nuclease-free water (Qiagen). RNA
concentration and integrity was determined by the Agi-
lent Bioanalyzer 2100 system (Agilent Technologies,
Additional file 2: Figure S1, Additional file 1: Table S1).
High throughput profiling of gene and miRNA expression
Gene expression profiling
Gene expression profiling was performed on 100 ng
RNA isolated from sorted G1, S and G2 phases of
HDFa, NCI-H295R and HeLa cells. In all, 24 samples (2
or 3 samples of each phase) were analyzed using Agi-
lent whole human genome 4x44K microarray slides
(Agilent Technologies) following the manufacturer’s
protocol [54].
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miRNA expression profiling using microarray
MiRNA expression profiling was performed on 100 ng
RNA isolated from sorted G1, S and G2 phases of HDFa
and NCI-H295R cells. In all, 16 samples (2 or 3 samples
of each phase) were analyzed. The miRNA expression
profiling using microarray followed the manufacturer’s
protocol [48]. Total RNA was labeled with Cy3 and
amplified using Low Input Quick Amp Labeling Kit ac-
cording to the manufacturer’s instructions. After RNA
purification, labeled RNA was hybridized to Agilent 8 ×
15 K Human miRNA Microarray Release 12.0. slides
(Agilent Technologies), according to the manufacturer’s
instructions. After washing, array scanning and feature
extraction was performed by Agilent DNA Microarray
Scanner and Feature Extraction Software 11.0.1.
miRNA expression profiling using TaqMan Low Density
Array (TLDA)
RNA isolated from two samples of G1 and three samples
of S and G2 phase-sorted NCI-H295R cells were studied
using TaqMan Low Density Array (TLDA) cards, accord-
ing to the manufacturer’s instructions. The miRNA expres-
sion profiling using TLDA was performed as previously
reported [55]. 30 ng of total RNA was reverse transcribed
and pre-amplified using Megaplex RT primer pool A and
B and Megaplex PreAmp primers, respectively. Quantita-
tive real-time PCR were carried out in TaqMan Human
MicroRNA Array A and B on a 7900HT Real time PCR
System (Applied Biosystems by Life Technologies).
miRNA expression profiling using Illumina small
RNA sequencing
Two samples of each cell cycle phase of HeLa cells (six
samples) and one sample of each cell cycle phase of
pooled sorted NCI-H295R cells (threee samples) were an-
alyzed. Small RNA sequencing was performed at BGI
using Illumina Small RNA Sequencing Platform. For li-
brary preparation TruSeq Small RNA library preparation
kit (Illumina, San Diego, California) was used. Sequencing
was performed by SE50 with Illumina HiSeq2000, and
10 Mb clean reads were analyzed followed by routine al-
gorithms (BGI Tech Solutions, Tai Po, Hong Kong).
qRT-PCR validation
For the gene expression qRT-PCR experiments, 30 ng of
total RNA was reverse transcibed using SuperScript VILO
cDNA synthesis kit according to the manufacturer’s in-
structions (Applied Biosystems by Life Technologies).
Gene expression was quantified using predesigned Taq-
man probes (Additional file 1: Table S2, Applied Biosys-
tems by Life Technologies) on a 7500 Fast Real-time
PCR system (Applied Biosystems by Life Technologies).
Gene expression data were normalized to the relative
expression of ACTB.
For the miRNA expression qRT-PCR experiments,
5 ng of total RNA was reverse transcribed and quantified
using TaqMan microRNA reverse transcription kit (Ap-
plied Biosystems by Life Technologies) and predesigned
TaqMan probes (Additional file 1: Table S2, Applied Bio-
systems by Life Technologies) on a 7500 Fast Real-time
PCR system (Applied Biosystems by Life Technologies).
MiRNA expression data were normalized to the relative
expression of RNU48.
All measurements were performed in triplicate (three
biological, two technical replicates). Expression level was
calculated by the ΔCt(S-phase) – ΔCt(G1-phase) and
the ΔCt(G2-phase) – ΔCt(G1-phase) (ΔΔCt) methods.
Pathway analysis
Ingenuity Pathway Analysis (IPA, Ingenuity Systems)
was used to detect molecular and cellular functions al-
tered between cell cycle phases. Δ(G2-G1) gene expres-
sion changes of significantly differently expressed genes
(NCI-H295R and HeLa) or genes with fold change > 2
expression (HDFa) were subjected to IPA core analysis.
Microarray data from former studies
Two former microarray studies identifying cell cycle
dependent expression of mRNA transcripts in human
primary fibroblasts [5] and HeLa cells [4] using
synchronization based procedures were selected. Proc-
essed data from these experiments were downloaded
from http://genome-www.stanford.edu/Human-Cell-
Cycle/HeLa/ [4] and from the European Bioinformat-
ics Institute Array Express database (http://
www.ebi.ac.uk/arrayexpress/experiments/E-TABM-
263/) [5] and were re-analyzed [4, 5]. Upon published
FACS analysis data, time points with highest levels of
synchronous populations of each cell cycle phase were
chosen to represent G1, S and G2 phases, respectively.
Difference in gene expression between phases was cal-
culated upon difference of normalized expression of a
certain gene between time points representing each
phase.
In these comparisons only those gene expression alter-
ations were used where the cell cycle sort indicated cell
cycle dependent gene expression changes (FC > 2 genes
of HDFa and significant genes of HeLa experiment).
Gene ontology term analysis
Gene Ontology (GO) term analysis was performed to de-
tect biological processes with enriched genes in the HeLa
cell cycle transcriptional program. The online functional
annotation tool of DAVID Bioinformatics Resources ver-
sion 6.7 (https://david.ncifcrf.gov/) with Gene Ontology
for biological processes (category: GOTERM_BP_FAT)
was used. The input gene lists for the analysis were the
genes unique to HeLa SORT experiment (HeLa SORT \
Grolmusz et al. BMC Genomics  (2016) 17:412 Page 13 of 16
HeLa synchr), unique to HeLa synchronization experi-
ment (HeLa synchr \ HeLa SORT) and the overlap be-
tween these two lists (HeLa SORT ∩ HeLa synchr).
Bonferroni-corrected p-values < 0.05 were considered sta-
tistically significant [4].
Analysis of gene expression levels and cell cycle
dynamics in primary and cancer cells
Analysis of gene expression levels and cell cycle dynam-
ics in different cell types were performed by investigating
the changes of 127 genes found to be cell cycle depend-
ently expressed in HDFa and HeLa cells. Upon com-
bined normalization of all cell cycle sort-based gene
expression microarrays, normalized intensity values in
each cell type in each cell cycle phase were compared.
For the analysis of the gene expression dynamism during
cell cycle progression the absolute values of fold changes
between cell cycle phases were calculated and were sub-
jected to comparison between HDFa, NCI-H295R and
HeLa cell types.
Results of qRT-PCR experiments in 10 (Additional file
1: Table S2) out of these 127 genes were also subjected
to these analyses. ΔCt values normalized to ACTB ex-
pression and absolute values of fold changes in cell cycle
phases were calculated and were compared in all cell
types.
Statistical analysis
Statistical analysis of the microarray data was per-
formed by GeneSpring 12.6 (Agilent Technologies)
software. Total signal normalization at the 75th per-
centile of raw signal values and baseline transformation
at the median of all samples following Agilent’s recom-
mendation were performed. Differently expressed genes
between G1, S and G2 phases were detected by one-
way ANOVA followed by Tukey’s Honestly Significant
Difference post hoc test and Benjamini-Hochberg cor-
rection for multiple measurements.
ΔCt levels of individually measured mRNA and miRNA
transcripts obtained by qRT-PCR measurements and sub-
sequent normalization to housekeeping transcripts (ACTB
or RNU48) were subjected to Students’ two sided inde-
pendent samples T-test. Differences were analyzed be-
tween G1-S, S-G2 and G1-G2 phases, respectively. Center
values shown are the average of replicate experiments.
On genes displaying cell cycle dependent expression re-
vealed by cell cycle sort, Pearson’s correlation was used to
calculate correlation between expression changes detected
by different (cell cycle sort and various synchronization)
methods.
Student’s two-sided paired samples T-test was used to
detect difference in normalized expression of genes
expressed in a cell cycle dependent manner between
various cell types. Student’s two-sided independent
samples T-test was used to detect difference in absolute
values of fold change of cell cycle dependently expressed
genes of various cell types. In all comparisons p-value
<0.05 was considered statistically significant.
Statistical analysis for miRNA expression analysis of
TLDA card was performed using Real-Time StatMi-
nerTM software (Integromics, Granada, Spain). Expres-
sion level was calculated by the ΔΔCt method, and fold
changes were obtained using the formula 2-ΔΔCt. Follow-
ing quality control, expression levels were normalized to
the geometric mean of all expressed miRNAs. One-way
ANOVA was used to detect significantly altered expres-
sion. In all comparisons p-value <0.05 was considered
statistically significant.
For identification of differentially expressed miRNAs
of Small RNA Sequencing experiments edgeR package
version 3.8.6 in R was used. Alignment to MirBase ver-
sion 21.0 mature miRNA database was performed on
reads longer than 18 nucleotides with maximum 1 mis-
match. The input data for edgeR package were the pair
of phases (G1-S, S-G2, G1-G2) with two samples for
each phases. The classical exact T-Test and TMM
normalization were applied. Benjamini and Hochberg’s
algorithm was used to control the false discovery rate
(FDR). The difference was statistically significant when
both the p-value and the FDR was <0.05.
Additional files
Additional file 1: Table S1. Characterization of cell cycle sorted cells
and isolated RNA quantity in various cell types. Purity of cell cycle sort
was determined by re-analyzing the sorted populations by FACS analysis:
percentage was determined by the portion of cells residing in the gate
previously designated for a certain cell cycle phase. Data of four replicate
experiments. Data are given as × 1000 cells (sorted cells) and are shown
as mean ± standard deviation. Table S2. Name and details of primers
used for mRNA and miRNA expression qRT-PCR measurements. mRNA
primers (Panel A, cat. No: 4331182) and miRNA primers (Panel B, cat. No:
4427975). All primers were from Applied Biosystems by Life Technologies.
Table S3. Normalized expression of differently expressed genes between
cell cycle phases in various cell types. Normalized expression of genes
with fold change > 2 between cell cycle phases detected in HDFa cells
(Panel A). Normalized expression of significantly differently expressed
genes in cell cycle phases detected in NCI-H295R (Panel B) and HeLa
(Panel C) cells. Note: For Panel B and C, genes are listed in the manner as
shown in the heat map (Fig. 2, panel A and B, respectively). Table S4. List
of genes shown on Venn diagram (Fig. 3, panel a). Genes are marked
with “1” if being found cycling by either method (HDFa SORT, PF synchr,
HeLa SORT, HeLa synchr). Gene IDs are Gene Symbols, if available or
probe IDs. Table S5. List of HeLa cell cycle genes being present in
enriched GO terms. Table 1 presents GO terms which are enriched in
gene lists unique to HeLa SORT, HeLa synchronization experiments and
the overlap beween HeLa SORT and synchronization lists. Gene symbols
of genes being present in the gene lists and the enriched GO terms are
shown here (HeLa SORT \ HeLa synchr - Panel A; HeLa synchr \ HeLa
SORT – Panel B; HeLa SORT ∩ HeLa synchr – Panel C). (XLS 743 kb)
Additional file 2: Figure S1. Quality and integrity of RNA isolated from
cell cycle sorted populations of G1, S and G2 phases of HDFa, NCI-H295R
and HeLa cells. Isolated RNA was analyzed on Agilent Bioanalyzer 2100
System. Representative results of G1, S and G2 populations sorted from
HDFa (Panel A), NCI-H295R (Panel B) and HeLa (Panel C) cells are shown.
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RNA integrity number (RIN) was calculated if RNA concentration
exceeded 10 ng/uL, therefore, in samples with lower RNA concentration
RIN is not shown. Figure S2. Supplementary functional bioinformatics
analysis of molecular and cellular functions concerned by gene
expression alterations in cell cycle phases. Panel A: HDFa, Panel B:
NCI-H295R, Panel C: HeLa. In Fig. 2, panels f-h only the five most
significantly concerned networks are shown. Additional molecular and
cellular functions are shown here. Figure S3. Pearson’s correlation
analysis of gene expression changes in cell cycle phases of cell cycle
sort and synchronization method in primary fibroblasts. Data of
synchronization experiments: [5]. Synchronization methods: SS – serum
starvation, SST – serum starvation followed by thymidine block. Correlation
coefficients are shown. Asterisks mark statistical significance (p < 0.05). Fig-
ure S4. Pearson’s correlation analysis of gene expression changes in cell
cycle phases of cell cycle sort and synchronization method in HeLa cells.
Data of synchronization experiments: [4]. Synchronization methods: DT –
double thymidine block, TN – thymidine followed by nocodazole block. Cor-
relation coefficients are shown. Asterisks mark statistical significance (p <
0.05). Figure S5. Illumina Small RNA Sequencing and qRT-PCR measuremnts
of cell cycle sorted NCI-H295R cells. Panel A: Fold change (log2) of miRNA
expression in S/G1, G2/S and G2/G1 phases observed by Illumina Small RNA
Sequencing. One pooled sample of each cell cycle phase was sequenced
and, therefore, no statistical analysis has been performed. Grey background
corresponds to fold change≤ 2 between cell cycle phases. Colored circles
represent some members of the hsa-miR-16 family, if available. Colored tri-
angles represent two chosen miRNAs with FC > 2 expression between G2/
G1 phases chosen to validate high-throughput data. Panel B: QRT-PCR
measurements of 4 miRNAs chosen to validate Illumina Small RNA Se-
quencing data. Hsa-miR-202 and hsa-miR-132 were chosen upon FC > 2
expression in cell cycle phases. Hsa-miR-24-2* and hsa-miR-577 were
chosen as G1 phase lacked miRNA expression, while in G2 phase miRNA
expression was
detectable. However, neither statistical examination detected significant
difference (p < 0.05). Error bars show standard deviation. Figure S6.
QRT-PCR measurements of miRNAs chosen to validate high-throughput
data in HDFa, NCI-H295R and HeLa cells. Hsa-miR-10b, hsa-miR-128a and
hsa-let-7 g were chosen upon TLDA screening of NCI-H295R cells.
Hsa-let-7a, hsa-let-7e and hsa-let-7f were chosen upon Small RNA
Sequencing of cell cycle sorted HeLa cells. MicroRNAs of stable expression
(hsa-let-7i, hsa-miR-21, hsa-miR-22 and hsa-miR-222) in all three cell types
and on all platforms were chosen to validate stable expression. Data from
HDFa cells (Panel A), NCI-H295R cells (Panel B) and HeLa cells (Panel C).
Additionally, hsa-miR-577 was also measured in HeLa cells, but it
showed no cell cycle dependent expression pattern (Panel D). Error bars
show standard deviation. Neither statistical examination detected significant
difference (p < 0.05). (TIF 636 kb)
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